Citalopram for Sx/Util in Acute Coronary Syndrome Patients
Status and phase
Conditions
Treatments
Details and patient eligibility
About
Symptoms (chest pain, shortness of breath, dizziness, etc.) and treatment usage (doctor or emergency room visits, testing, hospital days, etc.) in patients with Acute Coronary Syndromes are known to be related to emotional distress (Anxiety, Depression and Anger). In addition, behavioral treatment of emotional distress is known to decrease symptoms, and treatment usage. The present protocol tests whether the addition of a medication known to reduce emotional distress can also reduce symptoms and treatment usage.
This will done by recruiting patients with ACS during their hospital stay, randomizing them to receive citalopram or placebo, and then examining their symptoms and treatment usage at 6 months.
Full description
Not applicable. Study not funded.
Sex
Ages
Volunteers
Inclusion criteria
- Admission to hospital for chest pain/dyspnea, typical ECG changes plus positive tropinins
Exclusion criteria
- age less than 18
- cognitive impairment (per MMSE)
- geographic unavailability for followup
- unwillingness to participate
- illiteracy
- Hx cardiac transplant
- untreated hypothyroidism
- hepatic dysfunction
- prior adverse reaction to citalopram
- history of Bipolar Disorder
- untreated Sleep Apnea
- chronic steroid therapy
- active substance abuse (e.g., within past year)
- near term mortal illness
- current mental health treatment
- signitificant suicide risk
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal